Peer-Reviewed Publications

  1. Yanco BG., Nettlow A., Okafor JI., Park JY, and TeStrake D. Comparative antigenic studies of species of Basidiobolus and other medically important fungi. J. of Clin. Microbiol. 23(4):679-682. 1986 PMID:3084553. PMCID:PMC362815
  2. Ganguly R., and Park JY. Immunostimulating agent against Influenza virus infection in senescent rats. Allerg. Immunol. 34:239-247. 1988 PMID:3228058.
  3. TeStrake D, Park JY, and Yanco BG. Exoantigen comparisons of selected isolates of Basidiobolus species. Mycologia 81(2):284-288, 1989.
  4. Wille JJ, Park JY, and Elgavish A. Effects of growth factors, hormones, bacterial lipopolysaccharide, and lipotechoic acids on the clonal growth of normal urethral epithelial cells in serum-free culture. J. of Cell Physiol. 150:52-58. 1992 PMID:1730786
  5. Stephensen CB., Blount SR, Schoeb TR and Park JY. Vitamin A deficiency impairs some aspects of host response to influenza A virus infection in BALB/c mice. J. Nutr. 123:823-833. 1993 PMID:8487093
  6. Stephensen CB, Park JY and Blount SR. cDNA sequence analysis confirms that the etiologic agent of Callitrichid Hepatitis is Lymphocytic choriomeningitis virus. J. Virol. 69:1349-1352. 1995 PMID:7815520
  7. Park JY, Peters CJ, Rollin PE, Ksiazek TG, Gray G, Waites KB, and Stephensen CB. Development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus (LCMV) infection and its use in a prospective surveillance study. J. Med. Virol. 51:107-114. 1997 PMID:9021540.
  8. Park JY, Peters CJ, Rollin PE, Ksiazek TG, Katholi CR, Waites KB, GrayB, Maetz HM, and Stephensen CB. Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: Evidence of Decreased risk of Infection. Am. J. Trop. Med. Hyg. 57(1):37-41. 1997 PMID:9242315.
  9. Park JY, Muscat JE, Ren Q, Schantz SP, Harwick RD, Stern JC, Pike V, Richie JP Jr, and Lazarus P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epi. Biom. Prev. 6:791-797. 1997 Erratum in: Cancer Epidemiol Biomarkers Prev 1997 Dec;6(12):1108. PMID:9332761.
  10. Lazarus P, Sheikh SN, Ren Q, Schantz SP, Stern JC, Richie JP Jr, and Park JY. p53 but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use. Carcinogenesis 19(3):509-514. 1998 PMID:9525287.
  11. Qin GZ, Park JY, Chen SY and Lazarus P. A high prevalence of p53 mutations in premalignant oral erythroplakia. Int. J. Cancer 80:345-348. 1999 PMID:9935172.
  12. Park JY, Schantz SP, Stern JC, Kaur T, and Lazarus P. Association between glutathione S- transferase Pi genetic polymorphisms and oral cancer risk. Phamacogenetics 9:497-504. 1999 Erratum in: Pharmacogenetics 2000 10(4):371. PMID:10780269.
  13. Ren Q, Murphy SE, Dannenberg A, Park JY, Tephly TR, and Lazarus P. Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat UDT-glucuronosyltransferase 2B1. Drug metabolism and Disposition 27:1010-1016. 1999 PMID:10460800.
  14. Park JY, Muscat JE, Kaur T, Schantz SP, Stern JC, Richie JP and Lazarus P. Comparison of GSTM polymorphisms and risk for oral cancer between African Americans and Caucasians. Pharmacogenetics 10:123-131. 2000 PMID:10762000.
  15. Lazarus P and Park JY. Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncology 36:421-431. 2000 PMID:10964048.
  16. Liu S, Park JY. Schantz SP, Stern JC and Lazarus P. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncology 37(5):437-445. 2001 PMID:11377232.
  17. Zheng Z., Park JY, Guillemette C, and Lazarus P. The tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. Journal of National Cancer Institute. 93 (18):1411-1418. 2001 PMID:11562393.
  18. Elahi A, Zhong Z, Park JY, Eyring K, McCaffrey T, and Lazarus P The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 23:1229-1234. 2002 PMID:12117782.
  19. Park JY, Schantz SP and Lazarus P. Epoxide hydrolase genotype and orolaryngeal cancer risk: Interaction with GSTM1 genotype. Oral Oncology 39(5): 483-490. 2003 PMID:12747973. PMCID:PMC3715071.
  20. Chen L, Elahi A, {Szulkin, 2015 #12207}-Sang J, Lazarus P and Park JY. Association between polymorphism of human oxoguanine glycosylase 1 (hOGG1) and risk for prostate cancer. The Journal of Urology 170:2471-2474. 2003 PMID:14634453.
  21. Park JY, Chen L., Tockman M, Elahi A., and Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 14:103-109. 2004 PMID:15077011.
  22. Muscat J, Kleinman W, Colosimo S, Muir A, Lazarus P, Park JY, and Richie, JP Jr. Enhanced protein glutathiolation and oxidative stress in cigarette smokers. Free Radical Biology and Medicine 36(4):464-470. 2004 PMID:14975449.
  23. Park JY, Chen L, Shade K, Lazarus P, Seigne J, Patterson S., Helal M and Pow-Sang J. Asp85Tyr polymorphism in UDP-glucuronosyltransferase (UGT) 2B15 gene and risk of prostate cancer. Journal of Urology 171(6, Part 1 of 2):2484-2488. 2004 PMID:15126881.
  24. Kim JS, Park JY, Chung WY, Choi MA, Cho KS, and Park KK Polymorphisms in genes coding for enzymes metabolizing smoking-derived substances and the risk of periodontitis. J Clin Periodontol. 31(11):959-964. 2004 PMID:15491310
  25. Park JY, Chen L, Wadhwa N and Tockman MS. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. International Journal of Molecular Medicine 15:443-448. 2005 PMID:15702235.
  26. Park JY, Chen L, Lee JH, Sellers TA and Tockman MS. Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk. Lung Cancer 48:315-321. 2005 PMID:15892999.
  27. Park JY, Chen L, Elahi A, Lazarus P, and Tockman MS. Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk. European Journal of Cancer Prevention 14(3):223-230. 2005 PMID:15901990.
  28. Park JY, Brena RM, Gruidl M, Zhou J, Huang T, Plass C, and Tockman MS. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. Cancer Biomarkers 1(2-3):193-200. 2005 PMID:17192040.
  29. Chen L, Ambrosone CB, Lee JH, Sellers TA, Pow-Sang J. and Park JY. Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and risk of prostate cancer in white and black Americans. Journal of Urology 175(1):108-112, Discussion 112. 2006 PMID:16406883
  30. Park JY, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee JH, Dossett N, Lang N, Kadlubar FF, Ambrosone CB, Zachariah B, Heysek RV, Patterson S, and Pow-Sang J. The deletion polymorphism of the UDP-glucuronosyltransferase (UGT) 2B17 and risk of prostate cancer in African American and Caucasians. Cancer Epi. Biom. Prev. 15(8):1473-1478. 2006 PMID:16896035.
  31. Cha IH, Park JY, Chung WY, Choi MA, Kim HJ and Park KK. Polymorphism of the CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Medical Journal 48(2): 233-239. 2007 PMID:17461521.
  32. Park JY, Tanner JP, Sellers TA, Huang Y, Stevens CK, Dossett N, Shankar RA, Zachariah B, Heysek R, and Pow-Sang J. Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk. Urology 70(2):374-379. 2007 PMID:17826523.
  33. Park JY, Zheng W, Kim DH, Cheng JQ, Kumar N, Ahmad N, and Pow-Sang J. Candidate tumor suppressor gene SLC5A8 is frequently down regulated by promoter hypermethylation in prostate tumor. Cancer Detection and Prevention, 31(5):359-365. 2007 PMID:18037591.
  34. Park JY, Helm JF, Zheng W, Ly Q, Hodul PJ, Centeno BA, and Malafa MP. Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer. Pancreas, 2008, 36(4):e32-39. PMID:18437076.
  35. Varela-Lema L,Taioli E, Ruano-Ravina A, Barros-Dios JM, Benhamou S, Bhisey RA, Chen CJ, Coutelle C, Foulkes WD, Hayes RB, Katoh T, Lazarus P; Manni JJ, Morita S, Park JY, Roy B, Spitz, MR, Strange RC, Wei Q and Ragin, CC. Meta-analysis and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: a HuGE-GSEC review. Genetics in Medicine, 10(6):369-84. 2008 PMID:18496222. PMCID:PMC4036819
  36. Helm J, Centeno BA, Coppola D, Druta M, Park JY, Chen D, Hodul PJ, Kvols L, Yeatman TJ, Carey LC, Karl RC, and Malafa MP. Outcomes following resection of pancreatic adenocarcinoma: 20 years experience at a single institution. Cancer Control, 15(4):288-294. 2008 PMID:18813196.
  37. Evans DE, Park JY, Maxfield N, and Drobes DJ. Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators. Genes, Brain and Behavior, 8(1):86-96. 2009 PMID:19220487.
  38. 38. Park JY, Huang Y, and Sellers TA. Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk. Cancer Epidemiology. Volume 1, Host Susceptibility factors. Methods in Molecular Biology. 471:361-385. 2009 PMID:19109789. PMCID:PMC3968564
  39. 39. Helm J, Centeno BA, Coppola D, Melis M, Lloyd M, Park JY, Chen DT, and Malafa MP. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Cancer, 115(18):4080-4089 2009 PMID:19626671
  40. 40. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dörk T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, Fitzgerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; The UK ProtecT Study Collaborators; The PRACTICAL Consortium, Easton DF. Identification of seven novel prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics, 41(10):1116-1121 2009 PMID: PMCID:PMC2846760
  41. Park JY. Promoter hypermethylation in prostate cancer. Cancer Control, 2010, 17(4):245-255 PMID:20861812. PMCID:PMC3167691
  42. Chang B, Spangler E, Gallagher S, Haiman C, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom SA, Ingles S, Stern MC, Corral R, Joshi AD, Xu J, Giri VN, Rybicki B, Neslund-Dudas C, Kibel AS, Thompson IM, Leach RJ, Ostrander EA, Stanford JL, Witte J, Casey G, Eeles R, Hsing, AW, Chanock S, Hu JJ, John EM, Park JY, Stefflova K, Zeigler-Johnson C,,and Rebbeck TR.  Validation of Genome-Wide Prostate Cancer Associations in Men of African Descent. Cancer Epidemiol. Biomarkers Prev. 20(1): 23-32. 2011 PMID:21071540. PMCID:PMC3110616
  43. Ahn J, Kibel A, Park JY, Rebbeck T, Rennert H, Stanford J., Ostrander E, Chanock S, Wang MH, Mittal RD, Isaacs W, Platz E, and Hayes RB. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clinical Cancer Research, 17:1075-1081. 2011 PMID:21343373. PMCID:PMC3059497
  44. 44. Park JY, Helm JF, Coppola D, Malafa MP, and Kim SJ. microRNAs in pancreatic ductal adenocarcinoma. World Journal of Gastroenterology. 17(7):817-827. 2011 PMID:21412491. PMCID:PMC3051132
  45. Brim H, Kumar K, Nazarian J, Hathout Y, Jafarian A, Lee E, Green W, Smoot D, Park JY, Nouraie M, and Ashktorab H. SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas. PLoS One 6(6):e20216, 2011 PMID:21687703 PMCID:PMC3110579
  46. 46. Rollison DE, Epling-Burnette PK, Park JY, Lee JH, Park H. Jonathan K, Cole AL, Painter JS, Guerrier M, Melendez-Santiago J, Fulp W, Komrokji R, Lancet J, and List AF. Telomere length in myelodysplastic syndromes. Leukemia & Lymphoma. 52(8):1528-1536. 2011 PMID:21635204.
  47. Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Canzian F, Riboli E, Key T, Gronberg H, Hunter D, Kraft P, Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, Stanford JL, Ostrander EA, Sorensen KD, Dörk T, Andriole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Frank Gardiner RA, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brenner H, Habuchi T, Zhang HW, Lu YJ, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, O’Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, Tiina Wahlfors ED, Tammela TL, Klarskov P, Nordestgaard BG, Røder MA, Tybjærg-Hansen A, Bojesen SE, Travis R, Campa D, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S, Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Le Marchand L, Fitzgerald L, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK, Joshi AD, Shahabi A, Rinckleb AE, Ray A, Sellers TA, Lin HY, Stephenson RA, Farnham J, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW , Slavov C, Mitev V, The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology, The UK ProtecT Study Collaborators, The PRACTICAL Consortium, Easton DF, Eeles RA. Seven Prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics. 43(8):785-791. 2011 PMID:21743467 PMCID:PMC3396006
  48. Yi B, Kasai H, Lee HS, Kang Y, Park JY and Yang M. Inhibition by wheat sprout (Triticum aestivum) juice of bisphenol A induced oxidative stress in young women. Mutation Research. 724(1-2):64-68, 2011, PMID:21736952.
  49. Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell R, Jackson M, Kidd LC, Klob S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, Patrick AL, Rebbeck TR, Romana M, Standord JL, Ukoli F, Vancleave TT, Zeigler-Johnson CM, Mutetwa B and Ragin C. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32(9):1361-1369 2011 PMID:21705483. PMCID:PMC3165127
  50. Lee HS, Park JY and Yang M. Chemopreventive effects of Korean Red Ginseng (Panax ginseng C. A. Meyer) on exposure to polycyclic aromatic hydrocarbons. Journal of Ginseng Research. 35(3):339-343. 2011 PMID:23717078. PMCID:PMC3659533
  51. 51. Lin HY, Park HY, Radlein S, Mahajan N, Sellers TA, Zachariah B, Pow-Sang J, Coppola D, Ganapathy V, and Park JY. Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness. 78(4):971. e1-9. 2011 PMID:21802122. PMCID:PMC3190039
  52. Yang M, Park JY, and Tae K, Genome-wide evidence of XPC alteration in laryngeal squamous cell carcinoma. Asian Pacific Journal of Cancer Prevention. 12:1477-1481. 2011 PMID:22126485
  53. Lin HY, Chen A, Tsai YY, Qu X, Tseng TS and Park JY. TRM: A powerful two-stage machine learning approach for identifying SNP-SNP interactions. The Annals of Human Genetics. 76:53-62. 2012 PMID:22150548 PMCID:PMC3243917
  54. Yang, MH and Park JY. DNA methylation in promoter region and prostate cancer. Methods in Molecular Biology. 863:67-109. 2012 PMID:22359288 PMCID:PMC3715066
  55. Helm J, Coppola D, Ganapathy V, Lloyd M, Centeno BA, Chen D, Malafa MP and Park JY. SLC5A8 nuclear translocation and loss of expression are associated with poor outcome in pancreatic ductal adenocarcinoma. Pancreas. 41(6): 904-909. 2012 PMID:22450368
  56. Amankwah EK, Sellers TA and Park JY. Gene variants in angiogenesis pathway and prostate cancer. Carcinogenesis. 33(7):1259-69. 2012 PMID:22523086 PMCID:PMC3405650
  57. Jim HS, Park JY, Permuth-Wey J, Rincon, MA, Phillips KM, Small B and Jacobsen P. Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings. Brain, Behavior and Immunity. 26(7):1030-1036 2012 PMID: 22475653 PMCID:PMC3399038
  58. Lee HS, Isse T, Kawamoto T, Woo HS, Kim AK, Park JY and Yang M. Effects and action mechanisms of Korean pears (Pyrus pyrifolia cv. Shingo) on alcohol detoxification. Phytotherapy Research, 26(11): 1753–1758. 2012 PMID:22451246
  59. Wille JJ and Park JY. Retinoid and Ethanol-Sensitive Benzo(α)Pyrene Induction of Cytochrome P450 in Human Keratinocytes. Journal of Cancer Therapy. 3(6):1080-1085. 2012 DOI: 10.4236/jct. 2012.36141
  60. Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL, Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dörk T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M, Govindasami K, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Røder MA, Frikke-Schmidt R, Bojesen SE, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology; The UK ProtecT Study Collaborators; The Australian Prostate Cancer Bioresource; The PRACTICAL Consortium, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics. 22(2):408-415. 2013 PMID:23065704. PMCID:PMC3526158
  61. 61. Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Krehling J, Plass C, Smiraglia DJ, Tockman M and Kim SJ. Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer. Lung Cancer 79:198-204. 2013 PMID:23273563. PMCID:PMC3566332
  62. Amankwah EK, Anegbe E, Park HY, Pow-Sang J, Hakam A and Park JY. miR-21, miR221 and miR222 expression and prostate cancer recurrence among obese than non-obese cases. Asian Journal of Andrology 15:226-230. 2013 PMID:23353719. PMCID:PMC3705740
  63. Wille JJ and Park JY. Cell cycle arrest mediates global DNA methylation patterns in normal human keratinocytes, epidermoid carcinoma cells and murine embryonic fibroblasts. Journal of Cancer Therapy 2013 4(1):199-207.
  64. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative; stralian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Kote-Jarai Z, Easton DF. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nature Genetics 45(4):385-391. 2013 PMID:23535732 PMCID:PMC3832790
  65. Lin HY, Amankwah, EK, Tseng TS, Qu X, Chen, DT and Park JY. SNP-SNP interaction network in angiogenesis genes associated with prostate cancer aggressiveness. PLoS One 8(4):e59688 2013 PMID:23593148 PMCID:PMC3618555
  66. Park JY, Amankwah E, Anic GM, Lin HY, Walls B, Park H, Krebs K, Madden M, Niemeyer K, Marzban, S, Fang S, Chen W, Lee JE, Wei Q, Amos CI, Messina J, Sellers, TA, Sondak, V and Egan, KM. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol. Biomarkers Prev. 22(5):827-834 2013 PMID:23462921 PMCID:PMC3708315
  67. Lee HS, Isse T, Kawamoto T, Baik HW, Park JY and Yang M. Effect of Korean pear (Pyruspyrifolia cv. Shingo) juice on hangover severity following alcohol consumption Food and Chemical Toxicology 58:101-106 2013 PMID:23587660
  68. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S, Russel R, Dunning AM, Luccarini C, Dennis J, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Marchand LL, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle A, Clements JA, Teixeira MR, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dicks E, Baynes C, Conroy D, Bojesen SE, Kaaks R, Vincent D, Bacot F, Tessier DC; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology; The UK ProtecT Study Collaborators; The PRACTICAL Consortium, Easton DF, Eeles RA. Fine-mapping identifies multiple prostate cancer risk loci on 5p15 some associating with TERT expression. Human Molecular Genetics 22(12):2520-2528 2013 PMID:23535824 PMCID:PMC3658165
  69. Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY, Rollison DE. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiology 37:434-439 2013 PMID:23523330 PMCID:PMC3679277
  70. Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson B, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan C, Ragin C, Roberts R, Rybicki B, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson C. Global patterns of prostate cancer incidence, aggressiveness and mortality in men of African descent. Prostate Cancer volume 2013, article ID 560857 doi:10.1155/2012/560857. 2013 PMID:23476788 PMCID:PMC3583061
  71. Yi B, Kim CS, Han YS, Park MJ, Park JY and Yang MH. Association between endocrine disrupting phenols in colostrums and maternal and infant health. International Journal of Endocrinology. vol. 2013, article ID 282381, doi:10.1155/2013/282381. 2013 PMID:23737772 PMCID:PMC3662185
  72. Chornokur G, Amankwah EK, Davis SN, Phelan CM, Park JY, Pow-Sang J, and Kumar NB. Variation in HNF1B and obesity may influence prostate cancer risk in African American men: a pilot study. Prostate Cancer 2013:384594. PMID: 24386569 PMCID:PMC3872424
  73. Yeo CD, Kim JW, Cho MR, Kang JY, Kim SJ, Kim YK, Lee SH, Park CK, Kim SH, Park MS, Yim HW, and Park JY. Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions. Tuberc Respir Dis (Seoul). 75(6):244-249. 2013 PMID:24416055 PMCID:PMC3884112
  74. Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Jian G, Rachakonda PS, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, and Newton-Bishop J. An inherited variant in the gene coding for vitamin D binding protein and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res. 27(2):234-43 doi: 10.1111/pcmr.12193. 2014 PMID:24219834, PMCID:PMC4065372
  75. Lengacher CA, Reich RR, Kip K, Barta, M, Ramesar, S. Paterson, C, Moscoso MS, Carranza I, Budhrani PH, Kim SJ, Park HY, Jacobsen PB, Schell MJ, Jim HS, Post-White J, Farias JR, and Park JY. Influence of mindfulness-based stress reduction (MBSR) on telomerase activity in women with breast cancer. Biological Research for Nursing. 16(4):438-47 2014 PMID:24486564
  76. Kim SJ, Amankwah EK, Connors S, Park HY, Rincon M, Cornnell HH, Chornokur G, Ibrahim-Hashim A, Choi J, Tsai YY, Engelman R, Kumar NB,and Park JY. Safety and Chemopreventive effect of Polyphenoc E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prevention Research, 7:435-444. 2014 PMID:24501325 PMCID:PMC4123218
  77. Wille JJ, Burdge JJ, and Park JY. Methods for the Preparation of an Autologous Serum-free Cultured Epidermis and for Autografting Applications. Methods in Molecular Biology. 1195:203-218, 2014 PMID:24500900
  78. Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Severi G, Gronberg H, Aly M, Haiman CA, Schumacher F, Henderson BE, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Nordestgaard BG, Canzian F, Campa D, Riboli E, Key TJ, Travis RC, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Clements JA, Teixeira MR, Xu J, Mikropoulos C, Goh C, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Muir K, Eeles RA, Kote-Jarai Z. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet. 10(2):e1004129. doi:10.1371/journal.pgen. 1004129. eCollection 2014 PMID:24550738 PMCID:PMC3923678
  79. MacQueen DA, Heckman BW, Blank MD, Van Rensburg KJ, Park JY, Drobes DJ, and Evans DE. Variation in the Alpha 5 Nicotinic Acetylcholine Receptor subunit gene predicts cigarette smoking intensity as a function of nicotine Content. Pharmacogenomics Journal 14(1):70-6. 2014 PMID:23358500 PMCID:PMC3778124
  80. Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Rachakonda PS, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Bishop DT, Newton-Bishop J. Inherited variation in the PARP-1 gene and survival from melanoma. International Journal of Cancer. 135:1625-1633. 2014 PMID:24535833. PMCID:PMC4106984
  81. Long Q, Xu J, Osunkoya AO, Sannigrahi S, Johnson BA, Zhou W, Gillespie T, Park JY, Nam RK, Sugar L, Stanimirovic A, Seth AK, Petros JA, and Moreno CS. Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Research 74(12):3228-3237. 2014 PMID:24713434 PMCID:PMC4058362
  82. Wille JJ and Park JY. Effects of okadaic acid, retinoic acid and phorbol myristate acetate tumor promoter on oncogene expression. Journal of Cancer Therapy. 5(6):591-604 2014
  83. Ragin C and Park JY Biospecimens, Biobanking and Global Cancer Research Collaborations. eCancer Medical science 8:454. 2014 PMID:25228910 PMCID:PMC4154946
  84. Evans DE, MacQueen DA, Jentink, KG, Park JY, Lin HY and Drobes DJ. CHRNA5-variants moderate the effect of Nicotine Deprivation on a Neural index of Cognitive Control. Genes, Brain and Behavior 13(7):626-632. 2014 PMID:24934182 PMCID:PMC4178975
  85. Han Y, Signorello LB, Strom SS, Kittles RA, Rybicki BA, Stanford JL, Goodman PJ, Berndt SI, Carpten J, Casey G, Chu L, Conti DV, Rand KA, Diver WR, Hennis AJ, John EM, Kibel AS, Klein EA, Kolb S, Marchand LL, Leske MC, Murphy AB, Neslund-Dudas C, Park JY, Pettaway C, Rebbeck TR, Gapstur SM, Zheng SL, Wu SY, Witte JS, Xu J, Isaacs W, Ingles SA, Hsing A; The PRACTICAL Consortium; The ELLIPSE GAME-ON Consortium, Easton DF, Eeles RA, Schumacher FR, Chanock S, Nemesure B, Blot WJ, Stram DO, Henderson BE, Haiman CA. Generalizability of established prostate cancer risk variants in men of African-ancestry. International Journal of Cancer Jul 8. doi: 10.1002/ijc.29066. 2014 PMID:25044450
  86. Carastro LM, Lin HY, Park HY, Kim DH, Radlein S, Hampton KK, Hakam A, Zachariah B, Pow-Sang J, and Park JY. Role of p73 di-nucleotide polymorphism in prostate cancer and p73 protein isoform balance. Prostate Cancer. 2014:129582. doi: 10.1155/2014/129582. Epub 2014 Jul 6. 2014 PMID:25097786 PMCID:PMC4109114
  87. Tseng TS, Park JY, Zabaleta J, Moody-Thomas S, Sothern MS, Chen T, Evans DE, and Lin HY. Role of nicotine dependence on the relationship between genetic variants and risk of lung adenocarcinoma PLoS One 9(9):e107268 2014 PMID:25233467, PMCID:PMC4169410
  88. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Røder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokołorczyk D, Kluźniak W, Park JY, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G; The Breast and Prostate Cancer Cohort Consortium (BPC3); The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium; The COGS (Collaborative Oncological Gene-environment Study) Consortium; The GAME-ON/ELLIPSE Consortium, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nature Genet. 46(10):1103-1109. 2014 PMID:25217961
  89. Hale T, Weischer M, and Park JY. CHEK2*1100delC mutation and risk of prostate cancer. Prostate Cancer. volume 2014:294575, 2014 PMID:25431674
  90. Gallaher J, Cook LM, Gupta S, Araujo A, Dhillon J, Park JY, Scott JG, Pow-Sang J, Basanta D and, Lynch CC. Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling. Clinical & Experimental Metastasis. 31(8):991-9. 2014 PMID:25173680.
  91. Lengacher CA, Reich RR, Jim H, Ramesar, S. Budhrani P, Paterson CL, Farias JR, Shelton M, Moscoso, M, Park JY and Kip KE, The effect of Mindfulness based stress reduction (MBSR(BC)) on sleep quality in women with breast cancer: A randomized controlled trial. Psychooncology. 2015 24(4):424-32. PMID:24943918
  92. Na HK, Kim M, Chang SS, Kim SY, Park JY, Chung MW, and Yang M, Tobacco Smoking-Response Genes in Blood and Buccal Cells. Toxicology Letters 232(2):429-437 2015 PMID:25447457
  93. Lee I, Tran M, Evans-Nguyen T, Stickle D, Kim S, Han J, Park JY, and Yang M. Detoxification of Chlorella supplement on Heterocyclic Amines in Korean Young Adults. Environmental Toxicology and Pharmacology 2015 39(1):441-446. PMID: 25590673
  94. Park JY. Promoter hypermethylation as a biomarker in prostate adenocarcinoma. Methods Mol Biol.;1238:607-25. 2015 PMID: 25421683
  95. Stegeman S, Amankwah EK, Klein K, O’Mara T, Kim DH, Lin HY, Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Ali Amin Al Olama, Sara Benlloch, Kenneth Muir, Graham Giles, Wiklund F, Gronberg H, Haiman C, Schleutker J, Weischer M, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau C, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, PRACTICAL Consortium, Australian Prostate Cancer BioResource, Spurdle AB, Clements JA, Park JY*, and Batra J. Genome-wide association studies of miRSNPs identify novel functional prostate cancer risk SNPs. Cancer Discovery 2015 5(4):368-79 PMID: 25691096
  96. Gonzalez BD, Jim HS, Donovan KA, Small BJ, Sutton SK, Park JY, Lin HY, Spiess PE, Fishman MN, and Jacobsen PB. Course and Moderators of Hot Flash Interference During Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison. 2015 Journal of Urology. 194(3):690-5. PMID: 25791402
  97. Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal D, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman C, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler-Johnson C, Habuchi T, Thibodeau SN, Cooney K, Chappuis PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E, Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer. Epidemiol Biomarkers Prev. 2015 24(7):1121-9. PMID: 25837820
  98. Lengacher CA, Reich RR. Kip KE, Paterson CL, Park HY, Ramesar S, Jim HS, Alinat CB, and Park JY. Moderating Effects of Genetic Polymorphisms on Improvements in Cognitive Impairment in Breast Cancer Survivors Participating in a 6-week Mindfulness-Based Stress Reduction Program. Biological Research for Nursing 2015. 17(4):393-404. PMID: 25882604
  99. Gonzalez BD, Jim HS, Booth-Jones M, Small BJ, Sutton SK, Lin HY, Park JY, Spiess PE, Fishman MN, and Jacobsen PB. Course and Predictors of Cognitive Function in Prostate Cancer Patients Receiving Androgen Deprivation Therapy: A Controlled Comparison. 2015 Journal of Clinical Oncology. 33(18):2021-7. PMID: 25964245, PMCID: PMC4461804.
  100. Kang N, Choi ST, Kim YK, Yoo IR, Han DH, Lee DS, Kim YS, Hong SH, Kang JH, Lee KY, Park JK, Sung SW, Park, MS, Yim HW, Kim SJ and Park JY. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer. 2015 Lung Cancer, 89(2):99-103. PMID: 26101014.
  101. Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokołorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Viñuela A, Brown AA; PRACTICAL Consortium; COGS-CRUK GWAS-ELLIPSE (Part of GAME-ON) Initiative; Australian Prostate Cancer BioResource; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators, Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z. Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. 2015 Hum Mol Genet. 24(19):5589-602. PMID: 26025378.
  102. Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubiński J, Kluźniak W, Cannon-Albright L, Brenner H, Butterbach K, Stegmaier C, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, BioResource TA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Consortium TP, Gronberg H, Wiklund F. Prediction of individual genetic risk to prostate cancer using a polygenic score. 2015. Prostate. 2015 Sep;75(13):1467-1474. PMID: 26177737
  103. 103. Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, Easton DF, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, FitzGerald L, Henderson BE, Schumacher FR, Haiman CA, Sipeky C, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal D, Donovan JL, Hamdy FC, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubinski J, Kluzniak W, Cannon-Albright L, Brenner H, Herrmann V, Holleczek B, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva RP, Mitev VI, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha HS, Michael A, Kierzek A, Albanes D, Andriole GL, Berndt SI, Chanock SJ, Gapstur SM, Giovannucci EL, Hunter DJ, Kraft P, Le Marchand L, Ma J, Mondul AM, Penney KL, Stampfer M, Stevens VL, Weinstein SJ, Trichopoulou A, Bueno-de-Mesquita HB, Tjonneland A, Cox DG, Maehle L, Schleutker J, Lindstrom S, Wiklund F. Genome-Wide Association Study of Prostate Cancer-Specific Survival. Cancer Epidemiol Biomarkers Prev. 2015 24(11):1796-800. PMID: 26307654
  104. Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL consortium, Lathrop M, Smith GD, Martin RM. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. 2015 Cancer Causes and Control. 26(11):1603-16. PMID: 26387087
  105. Yang M, Youn JI, Kim SJ, and Park JY. Epigenetic Modulation of Chlorella (Chlorella vulgaris) on Exposure to Polycyclic Aromatic Hydrocarbons. 2015 Environmental Toxicology and Pharmacology. 40(3):758-763. PMID: 26432772
  106. 106. Harrell P, Lin HY, Park JY, Blank M, Drobes DJ, and Evans DE. Dopaminergic genetic variation moderates the effect of nicotine on cigarette reward. 2015 Psychopharmacology Oct 26. PMID: 26497691
  107. Saunders EJ, Dadaev T, Leongamornlert DA, Olama AA, Benlloch S, Giles GG, Wiklund F, Grönberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K; UK Genetic Prostate Cancer Study Collaborators; UK ProtecT Study Collaborators; PRACTICAL Consortium, Easton DF, Eeles RA, Kote-Jarai Z. Gene and Pathway Level Analyses of the Effect of Germline DNA Repair Gene Variants and Prostate Cancer Susceptibility using the iCOGS Genotyping Array. British Journal of Cancer. 2016 Mar 10. doi: 10.1038/bjc.2016.50. PMID: 26964030
  108. 108. Bull CJ, Bonilla C, Holly JM, Perks CM, Davies N, Haycock P, Yu OH, Richards JB, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, MacInnis RJ, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Micheal A, Pandha H, Smith GD, Lewis SJ, Martin RM; PRACTICAL consortium. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Med. 2016 5(6):1125-36. PMID: 26992435
  109. Wu ES, Park JY, Zeitouni J, Gomez CR, Reis IM, Zhao W, Kwon D4, Lee E, Nelson OL, Lin HY, Franzmann EJ, Savell J, McCaffrey TV, Goodwin WJ, and Hu JJ. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis. Head and Neck 2016 38(8):1234-41. PMID: 27028310
  110. Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, John EM, Murphy AB, Signorello LB, Carpten J, Leske MC, Wu SY, Hennis AJ, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Witte JS, Casey G, Kaggwa S, Cook MB, Stram DO, Blot WJ, Eeles RA, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Gronberg H, Wiklund F, Aly M, Henderson BE, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Teerlink C, Brenner H, Dieffenbach AK, Arndt V, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle A, Clements JA, Teixeira MR, Pandha H, Michael A, Paulo P, Maia S, Kierzek A; PRACTICAL consortium, Conti DV, Albanes D, Berg C, Berndt SI, Campa D, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giovannucci E, Hoover R, Hunter DJ, Johansson M, Kraft P, Le Marchand L, Lindström S, Navarro C, Overvad K, Riboli E, Siddiq A, Stevens VL, Trichopoulos D, Vineis P, Yeager M, Trynka G, Raychaudhuri S, Schumacher FR, Price AL, Freedman ML, Haiman CA, Pasaniuc B. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nature Communications 2016 Apr 7;7:10979. doi: 10.1038/ncomms10979. PMID: 27052111 PMCID: PMC4829663
  111. Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Davey Smith G; PRACTICAL consortium. Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. BMC Medicine 2016 14(1):66. doi: 10.1186/s12916-016-0602-x. PMID: 27044414 PMCID: PMC4820939
  112. Lengacher CA, Reich, RR, Paterson CL, Ramesar S, Park JY, Alinat C, Johnson-Mallard V, Moscoso M, Budhrani PH, Miladinovic B, Jacobsen PB, Cox CE, Goodman M, and Kip KE. Examination of Broad Symptom Improvement Resulting From Mindfulness-Based Stress Reduction in Breast Cancer Survivors: A Randomized Controlled Trial. Journal of Clincial Oncology. 2016 May 31. pii: JCO657874. PMID: 27247219
  113. Bonilla C, Lewis SJ, Rowlands MA, Gaunt TR, Smith GD, Gunnell D, Palmer T, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL consortium, Lathrop M, Martin RM, Holly JM. Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: genetic variants as instruments for circulating levels. International Journal of Cancer. 2016 139(7):1520-33. doi: 10.1002/ijc.30206. PMID: 27225428
  114. Das DK, Osborne JR, Lin HY, Park JY*, and Ogunwobi OO, miR-1207-3p is a novel prognostic biomarker of prostate cancer. Translational Oncology. 2016 9(3):236-41. PMID: 27267842
  115. Evans DE, Sutton S, Jentink KG, Lin HY, Park JY, and Drobes DJ, Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Indices of Cognitive Disruption during Nicotine Withdrawal. Genes Brain and Behavior 2016 15:621–626 PMID: 27453054 DOI: 10.1111/gbb.12311
  116. Pinheiro WO, Marques CR, Rios-Santos F, Fernandes MDB, Santos DB, Klein SOT, Oliveira FS, Gonzales A, Freitas DC, Park JY, and Di Pietro G. Association of the lipoprotein lipase S447X and neuropeptide Y Leu7Pro genetic polymorphisms with the lipid profiles of individuals with and without evidence of coronary artery disease. British Journal of Medicine & Medical Research 2016 DOI: 10.9734/BJMMR/2016/24670
  117. Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ; ABCTB Investigators, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, Gentry-Maharaj A, Whittemore AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A, Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A; AOCS Study Group & Australian Cancer Study (Ovarian Cancer); APCB BioResource, Ziogas A, Ekici AB, Burwinkel B, Karlan BY, Nordestgaard BG, Blomqvist C, Phelan C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Stegmaier C, Maier C, Ambrosone CB, Høgdall CK, Teerlink CC, Kang D, Tessier DC, Schaid DJ, Stram DO, Cramer DW, Neal DE, Eccles D, Flesch-Janys D, Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer EJ, Bandera EV, Poole EM, Goode EL, Khusnutdinova E, Høgdall E, Song F, Bruinsma F, Heitz F, Modugno F, Hamdy FC, Wiklund F, Giles GG, Olsson H, Wildiers H, Ulmer HU, Pandha H, Risch HA, Darabi H, Salvesen HB, Nevanlinna H, Gronberg H, Brenner H, Brauch H, Anton-Culver H, Song H, Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, Lubiński J, Stanford JL, Benítez J, Doherty JA, Permuth JB, Chang-Claude J, Donovan JL, Dennis J, Schildkraut JM, Schleutker J, Hopper JL, Kupryjanczyk J, Park JY, Figueroa J, Clements JA, Knight JA, Peto J, Cunningham JM, Pow-Sang J, Batra J, Czene K, Lu KH, Herkommer K, Khaw KT; kConFab Investigators, Matsuo K, Muir K, Offitt K, Chen K, Moysich KB, Aittomäki K, Odunsi K, Kiemeney LA, Massuger LF, Fitzgerald LM, Cook LS, Cannon-Albright L, Hooning MJ, Pike MC, Bolla MK, Luedeke M, Teixeira MR, Goodman MT, Schmidt MK, Riggan M, Aly M, Rossing MA, Beckmann MW, Moisse M, Sanderson M, Southey MC, Jones M, Lush M, Hildebrandt MA, Hou MF, Schoemaker MJ, Garcia-Closas M, Bogdanova N, Rahman N; NBCS Investigators, Le ND, Orr N, Wentzensen N, Pashayan N, Peterlongo P, Guénel P, Brennan P, Paulo P, Webb PM, Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow R, Kopperud RK, Schmutzler RK, Stephenson RA, MacInnis RJ, Hoover RN, Winqvist R, Ness R, Milne RL, Travis RC, Benlloch S, Olson SH, McDonnell SK, Tworoger SS, Maia S, Berndt S, Lee SC, Teo SH, Thibodeau SN, Bojesen SE, Gapstur SM, Kjær SK, Pejovic T, Tammela TL; GENICA Network; PRACTICAL consortium, Dörk T, Brüning T, Wahlfors T, Key TJ, Edwards TL, Menon U, Hamann U, Mitev V, Kosma VM, Setiawan VW, Kristensen V, Arndt V, Vogel W, Zheng W, Sieh W, Blot WJ, Kluzniak W, Shu XO, Gao YT, Schumacher F, Freedman ML, Berchuck A, Dunning AM, Simard J, Haiman CA, Spurdle A, Sellers TA, Hunter DJ, Henderson BE, Kraft P, Chanock SJ, Couch FJ, Hall P, Gayther SA, Easton DF, Chenevix-Trench G, Eeles R, Pharoah PD, Lambrechts D. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. 2016 6(9):1052-67. PMID: 27432226
  118. Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. BMC Cancer 2016 16(1):557, PMID: 27473687. PMCID:PMC4966583 DOI: 10.1186/s12885-016-2572-y
  119. Wille JJ and Park JY. Enhancement of Clonal Growth of Normal Human Keratinocytes in a Serum-free Medium by Lithium Ions, Dibutryl-Cyclic AMP and Prostaglandin E1. 2016 Global Dermatology 3(5): 374-378, doi: 10.15761/GOD.1000191
  120. Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Burwinkel B, Yang R, Guénel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Menéndez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA, Brenner H, Arndt V, Stegmaier C, Brauch H, Brüning T, Ko YD, Muranen TA, Aittomäki K, Blomqvist C, Bogdanova NV, Antonenkova NN, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle AB, Investigators K; Australian Ovarian Cancer Study Group, Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnæs GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila S, Devilee P, Tollenaar RA, Seynaeve C, Hollestelle A, Garcia-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H, Eriksson M, Eccles DM, Rafiq S, Tapper WJ, Gerty SM, Hooning MJ, Martens JW, Collée JM, Tilanus-Linthorst M, Hall P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres D, Ulmer HU, Rüdiger T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Swerdlow A, Ashworth A, Orr N, Jones M, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles R, Muir K, Wiklund F, Gronberg H, Schleutker J, Nordestgaard BG, Weischer M, Travis RC, Neal D, Donovan JL, Hamdy FC, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Schaid DJ, Kelley JL, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Butterbach K, Park JY, Kaneva R, Batra J, Teixeira MR, Kote-Jarai Z, Olama AA, Benlloch S, Renner SP, Hartmann A, Hein A, Ruebner M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, Nickels S, Eilber U, Wang-Gohrke S, Odunsi K, Sucheston-Campbell LE, Friel G, Lurie G, Killeen JL, Wilkens LR, Goodman MT, Runnebaum I, Hillemanns PA, Pelttari LM, Butzow R, Modugno F, Edwards RP, Ness RB, Moysich KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, Høgdall E, Peissel B, Bonanni B, Bernard L, Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Larson MC, Fogarty ZC, Kalli KR, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, Terry KL, Poole EM, Stampfer M, Tworoger SS, Bandera EV, Orlow I, Olson SH, Bjorge L, Salvesen HB, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean Y, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, Górski B, Gronwald J, Menkiszak J, Høgdall CK, Lundvall L, Nedergaard L, Engelholm SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Phelan CM, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Tsai YY, Chen Z, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Song H, Winship I, Chenevix-Trench G, Giles GG, Tavtigian SV, Easton DF, Milne RL. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. 2016 PMID: 27595995
  121. Brunner C, Davies NM, Martin RM, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles G, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Donovan J, Hamdy FC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL Consortium, Collins A, Zuccolo L. Alcohol Consumption and Prostate Cancer Incidence and Progression: a Mendelian Randomisation Study. International Journal of Cancer 2016 PMID: 27643404
  122. Wille JJ, and Park JY. Induced differentiation of epithelioid carcinoma cell lines: Evidence for tumor cell quantal mitosis. Journal of Cancer Therapy 2016 7(10):1-10
  123. Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Donovan JL, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Zheng W; PRACTICAL consortium. Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium. British Journal of Cancer 115(5):624-31 2016 PMID: 27490808
  124. Das DK, Naidoo M, Ilboudo A, Park JY, Ali T, Krampis K, Robinson BD, Osborne JR, Ogunwobi OO. miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin. 2016. pii: S0014-4827(16)30313-5. doi: 10.1016/j.yexcr.2016.09.021. Experimental Cell Research. PMID: 27693493
  125. Reich R1, Lengacher C2, Alinat C3, Kip K3, Paterson 3, Ramesar 3, Han H4, Ismail-Khan 4, Johnson-Mallard 5, Moscoso 3, Budhrani-Shani 6, Shivers 7, Cox C8, Goodman 9, and Park JY. Mindfulness-Based Stress Reduction in Post-Treatment Breast Cancer Patients: Immediate and Sustained Effects across Multiple Symptom Clusters 2016 Journal of Pain and Symptom Management Oct 5. pii: S0885-3924(16)30333-5. doi: 10.1016/j.jpainsymman.2016.08.005. [Epub ahead of print]. PMID: 27720794
  126. Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Blot W, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H; PRACTICAL Consortium, Donovan J, Munafò MR. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. 2016 International Journal of Cancer Oct 14. doi: 10.1002/ijc.30462. [Epub ahead of print] PMID: 27741566

In press/Accepted

  1. Kumar NB, Pow-Sang J, Spiess PE, Park JY, Chornokur G, Leone AR and Phelan CM. Chemoprevention in African American men with prostate cancer. Cancer Control. 2016
  2. Lin HY, Cheng CH, Chen DT, Chen YA and Park JY. Coexpression and eQTL Analyses of the Angiogenesis Gene-Gene Interaction Network in Prostate Cancer. Translational Cancer Research 2016
  3. Nagi B. Kumar, Julio Pow-Sang, Philippe E. Spiess, Park JY, Raoul Salup, Mohamed Helal, Christopher R. Williams, Howard Parnes and Michael J. Schell. Randomized, Placebo-Controlled Trial Evaluating the Safety of One-Year Administration of Green Tea Catechins. 2016 Oncotarget
  4. Richard R. Reich, Cecile A. Lengacher, Thomas W. Klein, Cathy Newton, Steve Shivers, Sophia Ramesar, Carissa B. Alinat Carly Paterson,  Alice Le, Park JY,  Versie Johnson-Mallard, Maya Elias, Manolete Moscoso, Matthew Goodman, Kevin E. Kip, A Randomized Controlled Trial of Mindfulness-Based Stress Reduction (MBSR(BC)) for Examining Changes in Inflammatory Biomarkers among Recovering Breast Cancer Survivors. 2016 Biological Research for Nursing
  5. 131. Di Pietro G, Chornokur G, Kumar N, Davis C and Park JY. Ethnic differences in Prostate Cancer Diagnosis and Treatment. 2016 International Neurourology Journal
  6. Wille JJ, Park JY and Shealy, YF. Cancer Chemopreventive Retinoids: Validation and Analysis of In Vivo and In Vitro Bioassay Results. 2016 ‘Cancer Causes and Prevention’ Special Edition, Journal of Cancer Therapy

Revision Requested

  1. 133. Heather S.L. Jim, Brian D. Gonzalez, Park JY, Brent J. Small, Steven K. Sutton, Joseph A. Pidala, Paul B. Jacobsen. Associations of Germline Genetic Variants with Depression and Fatigue among Hematologic Cancer Patients Treated with Allogeneic Hematopoietic Cell Transplantation: A Pilot Study. Brain, Behavior, and Immunity 2016
  2. Hui-Yi Lin, Dung-Tsa Chen2, Po-Yu Huang3, Yung-Hsin Liu4, Augusto Ochoa5, Jovanny Zabaleta5, Sellers TA, Julio Pow-Sang7, Chia-Ho Cheng2, Rosalind Eeles 1, 2, Doug Easton 3, Zsofia Kote-Jarai 1, Ali Amin Al Olama 3, Sara Benlloch 3, Kenneth Muir 4, Graham G. Giles 5, 6, Fredrik Wiklund 7, Henrik Gronberg 7, Christopher A. Haiman 8, Johanna Schleutker 9, 10, Børge G. Nordestgaard 11, Ruth C. Travis 12, David Neal 13, Nora Pashayan 14,33, Kay-Tee Khaw 15, Janet L. Stanford 16, 17, William J. Blot 18, Stephen N. Thibodeau 19, Christiane Maier 20, 21, Adam S. Kibel 22, 23, Cezary Cybulski 24, Lisa Cannon-Albright 25, Hermann Brenner 26,27,34, Radka Kaneva 29, Jyotsna Batra 30, Manuel R. Teixeira 31, Hardev Pandha32, Yong-Jie Lu35, and the PRACTICAL consortium and Park JY. SNP Interaction Pattern Identifier (SIPI): An Approach to the Intensive Search for SNP-SNP Interaction Patterns. Bioinformatics 2016 submitted on 09/29/2016
  3. 135. Wille JJ and Park JY. Wound Healing of Chronic Leg Ulcers Is Stimulated by Wound Edge Continuity with Adult Cultured Epidermal Autografts 2016 MOJ Cell Science & Report
  4. Fahad Mukhtar, Paolo Boffetta, Harvey A. Risch, Park JY, Omonigho M Bubu, Lindsay Womack, Thuan V. Tran, Janice C. Zgibor, Hung N. Luu. Survival predictors of burkitt’s lymphoma in children, adults and elderly in the united states during 2000-2013. 2016 International Journal of Cancer

Submitted

  1. Troy A. Webber, Heather E. Soder, Geoffrey F. Potts, Park JY, Marina A. Bornovalova. Genetic Moderation of Peer-influenced Risk-taking Behavior: Phenotypic and Endophenotypic Evidence. Experimental and Clinical Psychopharmacology 2016 on 08/22/2016
  2. Alinat CB, Lengacher CA, Rodriguez C, Park JY. Mindful Eating and Weight Loss: A Systematic Review of Literature. 2016 Journal of Alternative and Complementary Medicine.
  3. Siri H. Strand, Michal Switnicki, Mia Moller, Christa Haldrup, Tine Mai Storebjerg, Jakob Hedegaard, Iver Nordentoft, Soren Hoyer, Michael Borre, Jakob Skou Pedersen, Peter J. Wild, Park JY, Torben F. Orntoft and Sorensen KD. RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. 2016 Clincial Cancer Research 08/22/2016
  4. Nahyeon Kang1,2, Su Yeon Choi1,2, Bit Na Kim1,2, Chang Dong Yeo1,2, Chan Kwon Park1,2, Jin Woo Kim1, Sang Haak Lee1,2, Young Kyoon Kim1, Dong Soo Lee2,3, Seong-Beom Lee4, Sug Hyung Lee5, Park JY and Seung Joon Kim1,2. Hypoxia-induced angiogenesis, the epithelial–mesenchymal transition, and the acquisition of stemness in lung cancer. 2016 Sumitted to Molecular Cancer Research on 8/29/2016
  5. Hung N. Luu, Hui-Yi Lin, Karina Dalsgaard Sørensen, Olorunseun Ogunwobi, Nagi Kumar, Ganna Chornokur, Cathy Phelan, Dominique Jones, LaCreis Kidd, Jyotsna Batra, Kosj Yamoah, Anders Berglund, Robert Rounbehler, Mihi Yang, Sanghak Lee, Nahyun Kang, Seung Joon Kim, Park JY* and Giuliano Di Pietro.. miRNAs associated with Aggressiveness of Prostate Cancer. microRNAs in Toxicology and Medicine. 2016 BMC Urology on 9/14/2016
  6. 142 Park JY Lengacher CA, Richard R. Reich, Carissa B. Alinat, Le A, Sophia Ramesar, Carly Paterson, Hyun Y. Park, John Kiluk, Hyo Han, Roohi Ismail-Khan, Kevin E. Kip.  A role of Genetic polymorphisms in a Mindfulness-Based Stress Reduction program for Breast Cancer Survivors (MBSR(BC)) 2016 BRN submitted 09/30/2016